ATFLUNOV Trademark

Trademark Overview

On Wednesday, October 10, 2007, a trademark application was filed for ATFLUNOV with the United States Patent and Trademark Office. The USPTO has given the ATFLUNOV trademark a serial number of 79045472. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, October 10, 2017. This trademark is owned by NOVARTIS AG. The ATFLUNOV trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
atflunov

General Information

Serial Number79045472
Word MarkATFLUNOV
Filing DateWednesday, October 10, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, October 10, 2017
Registration Number3468316
Registration DateTuesday, July 15, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2008

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, August 7, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Trademark Events

Event DateEvent Description
Wednesday, May 30, 2018UNDELIVERABLE MAIL - NO ACTION TAKEN
Friday, May 11, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, May 11, 2018DEATH OF INTERNATIONAL REGISTRATION
Thursday, May 19, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, July 11, 2015NOTIFICATION PROCESSED BY IB
Friday, August 22, 2014NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, August 22, 2014DEATH OF INTERNATIONAL REGISTRATION
Sunday, April 28, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, March 23, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 7, 2009NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 4, 2008FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, November 4, 2008FINAL DISPOSITION PROCESSED
Friday, October 17, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 15, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, April 29, 2008PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2008NOTICE OF PUBLICATION
Tuesday, March 25, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 25, 2008ASSIGNED TO LIE
Monday, March 10, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 3, 2008NON-FINAL ACTION MAILED
Monday, March 3, 2008NON-FINAL ACTION WRITTEN
Friday, February 8, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 8, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 8, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 10, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 10, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 4, 2008REFUSAL PROCESSED BY IB
Friday, December 14, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 14, 2007REFUSAL PROCESSED BY MPU
Friday, December 14, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 13, 2007NON-FINAL ACTION WRITTEN
Saturday, December 8, 2007ASSIGNED TO EXAMINER
Monday, November 26, 2007NEW APPLICATION ENTERED IN TRAM
Friday, November 23, 2007LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, November 22, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

atflunov human vaccines